1. ALLA AKTIER
  2. NYHETER
  3. AEGIRBIO

AegirBio

Nyheter AegirBio Nyheter alla bolag

Magnasense and Salignostics Successfully Complete Feasibility Study

Magnasense and Salignostics are pleased to announce the successful completion of their feasibility study, initiated in September 2024. The study evaluated the transfer of an existing Salignostics test onto Magnasense’s platform. The results confirmed the compatibility of Salignostics’ collection device with Magnasense’s proprietary magnetic technology.

Marco Witteveen, CEO of Magnasense AB, stated:
“At Magnasense, we are committed to advancing diagnostic technology. Our collaboration with Salignostics has provided valuable insights into the potential of our magnetic test strip platform. We are encouraged by the study’s results and look forward to further developments.”

Dr. Guy Krief, Deputy CEO of Salignostics LTD, added:
“We are pleased with the study’s outcome, which highlights the synergy between our sample collection expertise and Magnasense’s magnetic technology. We look forward to exploring future opportunities together.”

The data in this feasibility study is the property of Salignostics LTD.

For additional information, please contact:
Marco Witteveen, CEO, Magnasense AB
Email: ir@magnasense.com
The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se

About Magnasense AB
Magnasense is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, Magnasense was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Magnasense's website www.magnasense.com.

Attachments
Magnasense and Salignostics Successfully Complete Feasibility Study

Datum 2025-05-01, kl 10:32
Källa MFN
Bifogade filer
Magnasense and Salignostics Successfully Complete Feasibility Study
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.